Twice-weekly topical corticosteroid therapy may reduce atopic dermatitis relapses.
Williams
Hywel C
HC
Queen's Medical Center University Hospital NHS Trust, Nottingham, England. hywel.williams@nottingham.ac.uk
D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D000730:Androstadienes / Q000008:administration & dosage*; D002648:Child; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004643:Emollients; D005260:Female; D000068298:Fluticasone; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D055502:Secondary Prevention; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000730:Androstadienes; D004643:Emollients; D000068298:Fluticasone